Filing Details

Accession Number:
0001214659-24-006771
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-12 19:00:18
Reporting Period:
2024-04-10
Accepted Time:
2024-04-12 19:00:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1721484 Longeveron Inc. LGVN Pharmaceutical Preparations (2834) 472174146
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1845308 Rock Soffer 1951 Nw 7Th Avenue
Suite 520
Miami FL 33136
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-04-10 106,383 $2.35 176,619 No 4 P Direct
Class A Common Stock Acquisiton 2024-04-11 31,915 $2.35 208,534 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Warrant (right to buy) Acquisiton 2024-04-10 106,383 $0.13 106,383 $2.35
Class A Common Stock Warrant (right to buy) Acquisiton 2024-04-11 31,915 $0.13 31,915 $2.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
106,383 2024-04-10 2029-04-10 No 4 P Direct
31,915 2024-04-11 2029-04-10 No 4 P Direct
Footnotes
  1. Share amounts include 64,010 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.